Human trial / 2025
Thymosin alpha-1 for sepsis: multicenter randomized phase 3 trial
Thymosin alpha-1 for sepsis: multicenter randomized phase 3 trial — PubMed (2025), cited in PeptideAgent's Thymosin Alpha-1 evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- PubMed
- Evidence type
- Human trial
- Publication year
- 2025
- Source ID
- pmid-39814420
WHERE THIS IS CITED